![Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies | Journal of Experimental & Clinical Cancer Research | Full Text Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02148-6/MediaObjects/13046_2021_2148_Fig1_HTML.png)
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies | Journal of Experimental & Clinical Cancer Research | Full Text
![Identification of Neurotoxicity after Chimeric Antigen Receptor (CAR) T Cell Infusion without Deterioration in the Immune Effector Cell Encephalopathy (ICE) Score - Biology of Blood and Marrow Transplantation Identification of Neurotoxicity after Chimeric Antigen Receptor (CAR) T Cell Infusion without Deterioration in the Immune Effector Cell Encephalopathy (ICE) Score - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/asset/602f3de0-be24-42de-88d6-cace1135e458/gr1.jpg)
Identification of Neurotoxicity after Chimeric Antigen Receptor (CAR) T Cell Infusion without Deterioration in the Immune Effector Cell Encephalopathy (ICE) Score - Biology of Blood and Marrow Transplantation
![Trial in Progress: A Phase 2, Single-Arm, Open-Label Study of Itacitinib (ITA) for the Prevention of Chimeric Antigen Receptor (CAR) T-Cell–Induced Cytokine Release Syndrome (CRS) - ScienceDirect Trial in Progress: A Phase 2, Single-Arm, Open-Label Study of Itacitinib (ITA) for the Prevention of Chimeric Antigen Receptor (CAR) T-Cell–Induced Cytokine Release Syndrome (CRS) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1083879119313655-gr9.jpg)
Trial in Progress: A Phase 2, Single-Arm, Open-Label Study of Itacitinib (ITA) for the Prevention of Chimeric Antigen Receptor (CAR) T-Cell–Induced Cytokine Release Syndrome (CRS) - ScienceDirect
![A Review of CAR T-Cell Therapies Approved for the Treatment of Relapsed and Refractory B-Cell Lymphomas A Review of CAR T-Cell Therapies Approved for the Treatment of Relapsed and Refractory B-Cell Lymphomas](https://jhoponline.com/images/jhop/2022/February/Review_CAR_T-Cell_table4.jpg)
A Review of CAR T-Cell Therapies Approved for the Treatment of Relapsed and Refractory B-Cell Lymphomas
![Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies | Journal of Experimental & Clinical Cancer Research | Full Text Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02148-6/MediaObjects/13046_2021_2148_Fig2_HTML.png)
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies | Journal of Experimental & Clinical Cancer Research | Full Text
![ICANS grading and management. Considerations and approaches for the... | Download Scientific Diagram ICANS grading and management. Considerations and approaches for the... | Download Scientific Diagram](https://www.researchgate.net/publication/332129666/figure/fig2/AS:825543784153094@1573836384791/ICANS-grading-and-management-Considerations-and-approaches-for-the-grading-and.png)
ICANS grading and management. Considerations and approaches for the... | Download Scientific Diagram
![Síndrome de neurotoxicidad asociada a células inmunoefectoras: un enfoque terapéutico en el paciente crítico | Medicina Intensiva Síndrome de neurotoxicidad asociada a células inmunoefectoras: un enfoque terapéutico en el paciente crítico | Medicina Intensiva](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//02105691/0000004600000004/v1_202203261024/S0210569120302448/v1_202203261024/es/main.assets/gr1.jpeg?xkr=dfhUZh+cpCdqta+flcPGXAWdthJkl6OkjGi2wxVdQHugE7U2BZXif5KTbqkTg4MrSyBtrgpPi9BEKVFHa5XkoKyTZw2//i08QJ136gLU5e26HANkgbQ60Ado1BWE9qOcpoiKCuy4v9/OO4Qk4Q0HuLUsOuENUNbLQhei+w3f/bKzk6mci5fDU5bhWEa3F4WP/8BtR1dWdGqh74r8TwFXisH0Rr28CUkWtnaH7AwgRoxMJ5BPJyD5XWfisk0macWnAbXP9WrB9Gp//qfUkvzLag==)
Síndrome de neurotoxicidad asociada a células inmunoefectoras: un enfoque terapéutico en el paciente crítico | Medicina Intensiva
![Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy | Nature Reviews Immunology Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy | Nature Reviews Immunology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41577-021-00547-6/MediaObjects/41577_2021_547_Fig4_HTML.png)
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy | Nature Reviews Immunology
![The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden | American Society of Clinical Oncology Educational Book The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden | American Society of Clinical Oncology Educational Book](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/edbk/2019/edbk.2019.39/edbk_238691/20190429/images/large/edbk_238691_table2.jpeg)
The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden | American Society of Clinical Oncology Educational Book
![Best practice recommendations for the management of ICANS following CAR... | Download Scientific Diagram Best practice recommendations for the management of ICANS following CAR... | Download Scientific Diagram](https://www.researchgate.net/publication/346490966/figure/fig3/AS:963554387714049@1606740676125/Best-practice-recommendations-for-the-management-of-ICANS-following-CAR-T-cell-therapy.png)
Best practice recommendations for the management of ICANS following CAR... | Download Scientific Diagram
![ICANS grading and management. Considerations and approaches for the... | Download Scientific Diagram ICANS grading and management. Considerations and approaches for the... | Download Scientific Diagram](https://www.researchgate.net/publication/332129666/figure/fig2/AS:825543784153094@1573836384791/ICANS-grading-and-management-Considerations-and-approaches-for-the-grading-and_Q320.jpg)
ICANS grading and management. Considerations and approaches for the... | Download Scientific Diagram
Síndrome de neurotoxicidad asociada a células inmunoefectoras: un enfoque terapéutico en el paciente crítico
![The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden | American Society of Clinical Oncology Educational Book The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden | American Society of Clinical Oncology Educational Book](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/edbk/2019/edbk.2019.39/edbk_238691/20190429/images/large/edbk_238691_table3.jpeg)
The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden | American Society of Clinical Oncology Educational Book
![Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy | Nature Reviews Immunology Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy | Nature Reviews Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41577-021-00547-6/MediaObjects/41577_2021_547_Fig1_HTML.png)
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy | Nature Reviews Immunology
![Frontiers | CAR T-cell-associated neurotoxicity in central nervous system hematologic disease: Is it still a concern? Frontiers | CAR T-cell-associated neurotoxicity in central nervous system hematologic disease: Is it still a concern?](https://www.frontiersin.org/files/Articles/1144414/fneur-14-1144414-HTML/image_m/fneur-14-1144414-g001.jpg)
Frontiers | CAR T-cell-associated neurotoxicity in central nervous system hematologic disease: Is it still a concern?
![Neurological management and work-up of neurotoxicity associated with CAR T cell therapy | Neurological Research and Practice | Full Text Neurological management and work-up of neurotoxicity associated with CAR T cell therapy | Neurological Research and Practice | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs42466-021-00166-5/MediaObjects/42466_2021_166_Fig3_HTML.png)
Neurological management and work-up of neurotoxicity associated with CAR T cell therapy | Neurological Research and Practice | Full Text
![Identification of Neurotoxicity after Chimeric Antigen Receptor (CAR) T Cell Infusion without Deterioration in the Immune Effector Cell Encephalopathy (ICE) Score - Biology of Blood and Marrow Transplantation Identification of Neurotoxicity after Chimeric Antigen Receptor (CAR) T Cell Infusion without Deterioration in the Immune Effector Cell Encephalopathy (ICE) Score - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/413f7260-b2dd-4ece-974d-68a40902de8d/gr1_lrg.jpg)
Identification of Neurotoxicity after Chimeric Antigen Receptor (CAR) T Cell Infusion without Deterioration in the Immune Effector Cell Encephalopathy (ICE) Score - Biology of Blood and Marrow Transplantation
![Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy | Nature Reviews Immunology Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy | Nature Reviews Immunology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41577-021-00547-6/MediaObjects/41577_2021_547_Fig2_HTML.png)